Zimmer Biomet Holdings ( (ZBH) ) has provided an announcement.
On February 25, 2025, Zimmer Biomet Holdings announced changes to its Board of Directors due to the mandatory retirement policy, with Chairman Christopher Begley set to retire at the 2025 Annual Meeting. Ivan Tornos, the current President and CEO, will assume the role of Chairman, while Michael Farrell will become the Lead Independent Director. These changes, effective May 29, 2025, aim to strengthen the company’s leadership and strategic direction.
More about Zimmer Biomet Holdings
Zimmer Biomet is a global leader in medical technology, offering a comprehensive portfolio aimed at enhancing mobility and health. The company utilizes innovative products and integrated digital and robotic technologies, leveraging data analytics and artificial intelligence to transform the patient experience. With over 90 years of expertise, Zimmer Biomet operates in more than 25 countries and sells in over 100 countries.
YTD Price Performance: 1.46%
Average Trading Volume: 1,711,383
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $21.1B
See more insights into ZBH stock on TipRanks’ Stock Analysis page.